Johns Hopkins Center for Psychedelic and Consciousness Research
Research to date demonstrate safety of psilocybin in regulated spaces facilitated by medical team over a series of guided sessions; and as a part of cognitive behavioral therapy, psilocybin helps in reducing anxiety in some cancer patients, and in facilitating smoking cessation for some.
Psilocybin Treatment for Major Depression Effective for Up to a …
2022年2月15日 · Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with ...
Potential Therapeutic Effects of Psilocybin - PMC
Here, we review therapeutic research on psilocybin, the classic psychedelic that has been the focus of most recent research. For mood and anxiety disorders, three controlled trials have suggested that psilocybin may decrease symptoms of depression and anxiety in the context of cancer-related psychiatric distress for at least 6 months following ...
The Therapeutic Potential of Psilocybin - PMC - PubMed Central …
A 2004 pilot study from the University of California, Los Angeles, exploring the potential of psilocybin treatment in patients with advanced-stage cancer managed to reignite interest and significantly renewed efforts in psilocybin research, heralding a new age in exploration for psychedelic therapy.
Psilocybin desynchronizes the human brain | Nature
2024年7月17日 · A single dose of psilocybin, a psychedelic that acutely causes distortions of space–time perception and ego dissolution, produces rapid and persistent therapeutic effects in human clinical trials...
Center for Psychedelic & Consciousness Research
Welcome to the world’s largest psychedelic science research center. Advancing the scientific understanding of psychedelics and their potential for treating mental health disorders, enhancing well-being, and expanding our understanding of consciousness.
Single-Dose Psilocybin for a Treatment-Resistant Episode of …
2022年11月2日 · Psilocybin is being studied for use in treatment-resistant depression. Methods. In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a...
Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative …
An experiment conducted at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center tested the efficacy of psilocybin in treating major depressive disorder. The team used a randomized, waiting list controlled trial to assess their patients’ results.
The emergence of psychedelics as medicine
2024年6月1日 · Psilocybin: Research has indicated rapid-acting and enduring antidepressant effects in combination with psychological support. Data also suggest potential efficacy for substance use disorders (alcohol use disorder and nicotine addiction), existential distress, and headache disorders.
Single-Dose Psilocybin Treatment for Major Depressive Disorder
This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients
- 某些结果已被删除